Bitcoin for the first time since the early September crash, is showing signs of its comeback.
Palantir Technologies is set to get its public listing on the New York Stock Exchange by the end of the month. The firm has chosen the Direct Listing process.
The event titled ‘Time Flies’ will be all about the Apple Watch, the iPad Air, Apple software, and will include a few interesting announcements.
With Tesla (TSLA) stock price jumping by 12.58% on Monday, the shares are still 16.5% below the September 1 record high.
As of midnight Eastern, Dow Jones Industrial Average futures were up around 300 points, or 1%, while S&P 500 futures jumped 1.2% and Nasdaq-100 futures gained 1.5%.
As the coronavirus pandemic persists, the OPEC trimmed outlook on oil demand in 2020, and the first six months in 2021.
Saudi Aramco’s market capitalization is currently 7.926 trillion Saudi Riyals (US$2.1 trillion), while Apple’s valuation is below $2 trillion.
It is a strategic partnership that will see both Merck and Seattle Genetics venture new market opportunities as the market demand for specialized and less harmful drugs sharply increases amid the crisis.
Stock markets are rallying as AstraZeneca resumes work after a short break in its clinical trials of the COVID-19 vaccine.
Bitcoin is up 0.68% today after losing 1.04% in price yesterday.
Ming Yuan Cloud Group Holdings Ltd is going to sell up to 374 million shares at a range of HK$15 to HK$16.50 through a Hong Kong IPO.
Following the announcement about the COVID-19 vaccine, Pfizer stock soared. On Friday, it closed 1.18% up, at $36.07 per share. In the early trading today, Pfizer shares are as much as 1.55% up, at $36.63.
Since the Gilead acquisition announcement was published, investors have gone extremely bullish on the shares of Immunomedics.
Apple investors and fans finally get a chance to experience Apple One bundled subscription products and AAPL stock is likely to skyrocket further.
In partnership with U.K.’s Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK’s Medicines Health Regulatory Authority.